Obstructions in Nanoparticles Conveyance, Nano-Drug Retention, and EPR Effect in Cancer Therapies

Author:

Fakhri Khalid Umar1ORCID,Sultan Armiya2,Mushtaque Md3,Hasan Mohammad Raghibul4,Nafees Sana2,Hafeez Zubair Bin1,Zafaryab Md1,Rizwanullah Md5ORCID,Sharma Deepti6,Bano Farhad7,AlMalki Waleed Hassan8,Ahmad Farhan Jalees9,Rizvi M. Moshahid Alam1

Affiliation:

1. Department of Biosciences, Jamia Millia Islamia, New Delhi, India

2. Jamia Millia Islamia, India

3. Al-Falah University, India

4. College of Applied Medical Sciences, Shaqra University, Al-Quwayiyah, Saudi Arabia

5. School of Pharmaceutical Education and Research, Jamia Hamdard, India

6. Institute of Nuclear Medicine and Allied Sciences, India

7. National Institute of Immunology, New Delhi, India

8. Umm Al-Qura University, Saudi Arabia

9. School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India

Abstract

In this chapter, the authors first review nano-devices that are mixtures of biologic molecules and synthetic polymers like nano-shells and nano-particles for the most encouraging applications for different cancer therapies. Nano-sized medications additionally spill especially into tumor tissue through penetrable tumor vessels and are then held in the tumor bed because of diminished lymphatic drainage. This procedure is known as the enhanced penetrability and retention (EPR) impact. Nonetheless, while the EPR impact is generally held to improve conveyance of nano-medications to tumors, it in certainty offers not exactly a 2-overlay increment in nano-drug conveyance contrasted with basic ordinary organs, bringing about medication concentration that is not adequate for restoring most malignant growths. In this chapter, the authors likewise review different obstructions for nano-sized medication conveyance and to make the conveyance of nano-sized medications to tumors progressively successful by expanding on the EPR impact..

Publisher

IGI Global

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Dendrimers based cancer nanotheranostics: An overview;International Journal of Pharmaceutics;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3